Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness and safety of Wilate vs Humate-P in von Willebrand disease type 3
IRCT2014020316468N1Phase 3Completed
- Sponsor
- Pourateb Pharmaceutical Company
- Start
- Aug 2016
- Countries
- 1
01
Overview
Phase 3 trial of von Willebrand factor concentrate in Type 3 von Willebrand disease (2 arms), sponsored by Pourateb Pharmaceutical Company. Started Aug 2016; status: completed.
02
Drugs
von Willebrand factor concentrate
03
Conditions
Type 3 von Willebrand disease
Beyond the preview
Go deeper on IRCT2014020316468N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014020316468N1.